Serotonin-3 Receptor Antagonist drugs compared
Compare all 4 Serotonin-3 Receptor Antagonist drugs side by side. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
Full ranking · 4 drugs
- 170/100
palonosetron hydrochloride
Palonosetron Hydrochloride
- 2New
granisetron hydrochloride
Granisetron Hydrochloride
- 3New
posfrea
Palonosetron Hydrochloride
- 4New
sancuso
Granisetron
Frequently asked questions
What is the Serotonin-3 Receptor Antagonist drug class?
Serotonin-3 Receptor Antagonist is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 4 Serotonin-3 Receptor Antagonist products, each independently rated.
Are all Serotonin-3 Receptor Antagonist drugs the same?
No. Serotonin-3 Receptor Antagonist drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
Sources: the Serotonin-3 Receptor Antagonist class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.